Journal of Commercial Biotechnology — October 2009 issue now available

September 28, 2009

in General Biotechnology, Talks and Publications

The October 2009 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 15, Issue 4

Editorial

Intellectual property and biotechnology innovation: To protect or not protect? PDF
Yali Friedman

Commentary

The correlation between medical tourism and biotechnology PDF
David G Vequist IV, Erika Valdez
The VC manifesto: Special pleading for a damaged cause: Commentary on Simon Witney interview PDF
William Bains

Articles

Innovate America: The Technology Innovation Program at NIST PDF
Andrew S Klein, Mrunal S Chapekar
Valuation of complex license contracts PDF
Ralph Villiger, Boris Bogdan
How can pharmaceutical and biotechnology companies maintain a high profitability? PDF
Klaus J Nickisch, Joachim M Greuel, Kerstin M Bode-Greuel
Multiyear patterns regarding the relative availability of venture capital for the US biotechnology industry PDF
J Leslie Glick
Building biotechnology teams: Personality does matter PDF
Anne S York, Kim A McCarthy, Todd C Darnold
Beacon Sciences: Commercialisation from biothreat detection to beauty enhancement PDF
Rob Hanes, Damon Borich

Legal and Regulatory Updates

Legal and Regulatory Update PDF
Gerry Kamstra, John Wilkinson

Book Reviews

Book Review: Genomics & society: Legal, ethical and social dimensions PDF
Dominic Clark
Book Review: Commercialization of innovative technologies: Bringing good ideas to the marketplace PDF
Arlen D Meyers
Book Review: Biotech funding trends: Insights from entrepreneurs and investors PDF
J Leslie Glick
Share this page
[Facebook] [Google] [LinkedIn] [Twitter] [Email]

Leave a Comment

Previous post:

Next post: